Zyla Life Sciences·4

Jul 1, 9:13 PM ET

Wilkins H Jeffrey 4

4 · Zyla Life Sciences · Filed Jul 1, 2019

Insider Transaction Report

Form 4
Period: 2019-07-01
Wilkins H Jeffrey
SVP and Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-07-01+190,000190,000 total
Footnotes (1)
  • [F1]Represents restricted stock units, which vest in three equal annual installments on the first three anniversaries of the date of grant.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -